Professional support for your Saypha® journey
Contact Cedal Persia for product information, availability and professional support for the Saypha® range.
0
PERSiTUS DP contains insulin glargine 100 IU/mL, a long-acting insulin analogue for once-daily subcutaneous use in insulin-dependent patients with type 1 or type 2 diabetes.
Product Overview
PERSiTUS DP contains insulin glargine 100 IU/mL, a long-acting insulin analogue of human insulin for blood glucose control in insulin-dependent patients.
Each pre-filled disposable pen contains 3 mL of sterile insulin glargine solution, equivalent to 300 IU. It provides the body's basal insulin requirement and supports long-term blood glucose control.
Indications
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus requiring insulin treatment for the control of hyperglycemia
For subcutaneous use once daily, as directed by a healthcare professional.